[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"pelvic-floor-dysfunction\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:pelvic-floor-dysfunction":27},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,11,0,[8,50,78,107,143,170,193,224,263,294,325],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":17,"sex":18,"minAge":19,"maxAge":4,"enrollmentInfo":20,"targetDuration":4,"studyType":23,"phases":4,"briefSummary":24,"conditions":25,"keywords":32,"overallStatus":38,"whyStopped":4,"lastUpdateSubmitDate":39,"lastUpdatePostDateStruct":40,"startDateStruct":43,"completionDateStruct":44,"leadSponsor":46,"locationsCount":49},"100633290","female-reproductive-health-in-canadian-armed-forces-100633290",false,"NCT07524764","Female Reproductive Health in Canadian Armed Forces","Female Reproductive Health in Canadian Armed Forces: Experience, Access to Care, and Support","BEARH2025","Inclusion Criteria (part 1):\n\n* Female (biological sex)\n* Aged at least 18 years old\n* Completed Basic Military Qualification (including Regular Forces, Reserve Forces (Class A, B, or C), Canadian Rangers, COATS instructors, and survivors of the LGBT Purge whose official records of service have been changed to reflect the nature of their discharge)\n\nInclusion Criteria (part 2):\n\n* Female (biological sex)\n* Aged at least 18 years old\n* Completed Basic Military Qualification (including Regular Forces, Reserve Forces (Class A, B, or C), Canadian Rangers, COATS instructors, and survivors of the LGBT Purge whose official records of service have been changed to reflect the nature of their discharge)\n* Have experienced a reproductive health issue while serving in the CAF\n\nInclusion Criteria (part 3):\n\n* Healthcare providers (CAF Health Services, public servant, civilian) who has treated female patients who are actively serving and\u002For Veterans of the CAF in the past 5 years.\n* Stakeholders who are involved in supporting reproductive health of female members of the CAF and\u002For Veterans.\n* Policymakers who are involved in supporting reproductive health of female members of the CAF and\u002For Veterans.",true,"FEMALE","18 Years",{"count":21,"type":22},1121,"ESTIMATED","OBSERVATIONAL","This is a mixed-method study aimed at gathering new evidence on reproductive health among female service members in the Canadian Armed Forces (CAF). Reproductive health includes four primary domains: contraception; undesired reproductive outcomes (including unintended pregnancy, adverse pregnancy outcomes, and infertility); assisted reproductive care; and pelvic floor dysfunctions. Additional factors that may influence reproductive outcomes will also be explored, including gynecological health (including but not limited to menstrual health, menopause, breast injury, sexually transmitted and blood-borne infections) as well as physical and psychological health (including but not limited to repetitive strain injuries, depression, and post-traumatic stress disorder). Evidence gathered on reproductive health issues will include, but not limited to, the lived experiences (occurrence), associated risk factors, access to care, including barriers and facilitators, service utilization, and career-related impacts among actively serving members and Veterans of the CAF. These will inform the development of recommendations and support services aimed at improving reproductive health care within the CAF. This project is divided into 3 convergent parts:\n\nPart 1: An online pan-Canadian survey that will achieve a minimum total sample of 1067 participants.\n\nPart 2: Semi-structured individual interviews (open-ended questions) will be conducted with female CAF members and Veterans who have experienced at least one reproductive health issues. A total of 30 participants are estimated to be required to achieve data saturation across the four primary domains.\n\nPart 3: Semi-structured group discussion (open-ended questions) will be conducted with healthcare providers, who have experience with treating female reproductive health issues in CAF members, as well as stakeholders and policymakers involved in supporting female members of the CAF\u002FVeterans. A total of 24 healthcare providers\u002Fstakeholders\u002Fpolicymakers will form 3 group discussion (8 participants\u002Fgroup).\n\nFor all 3 parts, efforts in recruitment will be made to ensure representation across CAF elements, minority groups, and native language (French and English).",[26,27,28,29,30,31],"Pregnancy","Pelvic Floor Dysfunction","Military Personnel","Contraception","Infertility","Women's Health",[33,34,26,30,35,29,36,37],"Reproductive health issue","Women's health","Pelvic floor dysfunction","Canadian Armed Forces","Military personnel","RECRUITING","2026-05-19",{"date":41,"type":42},"2026-05-22","ACTUAL",{"date":39,"type":42},{"date":45,"type":22},"2026-12-15",{"name":47,"class":48},"Université de Sherbrooke","OTHER",1,{"id":51,"slug":52,"hasResults":11,"nctId":53,"briefTitle":54,"officialTitle":54,"acronym":4,"eligibilityCriteria":55,"healthyVolunteers":17,"sex":18,"minAge":19,"maxAge":56,"enrollmentInfo":57,"targetDuration":4,"studyType":23,"phases":4,"briefSummary":59,"conditions":60,"keywords":65,"overallStatus":68,"whyStopped":4,"lastUpdateSubmitDate":69,"lastUpdatePostDateStruct":70,"startDateStruct":72,"completionDateStruct":74,"leadSponsor":76,"locationsCount":4},"100629706","maternal-musculoskeletal-factors-of-the-hip-lumbopelvic-abdominal-and-pelvic-floor-regions-and-their-association-with-mode-of-delivery-and-postpartum-pelvic-floor-dysfunction-100629706","NCT07478159","Maternal Musculoskeletal Factors of the Hip, Lumbopelvic, Abdominal and Pelvic Floor Regions and Their Association With Mode of Delivery and Postpartum Pelvic Floor Dysfunction","Inclusion Criteria:\n\n* Pregnant women aged 18 years or older\n* Singleton pregnancy\n* Gestational age of 36 weeks at the time of the baseline assessment\n* Receiving prenatal care in primary healthcare centers of Zaragoza (Spain)\n* Ability to understand study procedures and provide written informed consent\n\nExclusion Criteria:\n\n* Multiple pregnancy\n* High-risk pregnancy conditions that may affect labor progression or maternal musculoskeletal assessment (e.g., severe obstetric complications requiring planned cesarean section)\n* Previous pelvic floor surgery\n* Neurological or musculoskeletal disorders affecting the lumbopelvic or pelvic floor region\n* Inability to complete the assessment protocol or questionnaires","45 Years",{"count":58,"type":22},376,"This prospective observational cohort study aims to investigate the association between maternal musculoskeletal factors of the hip, lumbopelvic, abdominal, and pelvic floor regions and childbirth outcomes, as well as their consequences on pelvic floor function during the postpartum period. A total of 376 pregnant women will be recruited at 36 weeks of gestation and followed until 12 weeks postpartum. Musculoskeletal assessments will include hip range of motion, lumbopelvic mobility, abdominal muscle function, and pelvic floor strength and morphology. Obstetric outcomes such as mode of delivery and perineal trauma will be recorded after childbirth. The study will analyze whether maternal musculoskeletal function during late pregnancy is associated with delivery mode and pelvic floor dysfunction in the postpartum period.",[61,62,63,27,26,64],"Pelvic Floor Disorders","Urinary Incontinence","Perineal Trauma","Puerperium",[61,66,67,62],"Obstetric Labor","Complications Perineal Trauma","NOT_YET_RECRUITING","2026-03-12",{"date":71,"type":42},"2026-03-17",{"date":73,"type":22},"2026-05-01",{"date":75,"type":22},"2028-01-01",{"name":77,"class":48},"Universitat Internacional de Catalunya",{"id":79,"slug":80,"hasResults":11,"nctId":81,"briefTitle":82,"officialTitle":83,"acronym":4,"eligibilityCriteria":84,"healthyVolunteers":11,"sex":18,"minAge":19,"maxAge":85,"enrollmentInfo":86,"targetDuration":4,"studyType":23,"phases":4,"briefSummary":88,"conditions":89,"keywords":91,"overallStatus":38,"whyStopped":4,"lastUpdateSubmitDate":98,"lastUpdatePostDateStruct":99,"startDateStruct":101,"completionDateStruct":103,"leadSponsor":105,"locationsCount":49},"100575811","relationship-between-pelvic-floor-dysfunctions-and-lower-limb-strength-and-activation-in-ms-patients-100575811","NCT06777134","Relationship Between Pelvic Floor Dysfunctions and Lower Limb Strength and Activation in MS Patients","Relationship Between Pelvic Floor Dysfunctions and Core Endurance, Hip Rotation Muscle Strength, Tibialis Anterior and Tibialis Posterior Muscle Activation in Patients With Multiple Sclerosis","Inclusion Criteria:\n\n* EDSS score between 0 and 4.0\n* Having access to the internet via a high-speed smartphone or computer\n* Scoring at least 21 points on the MoCA\n* Having a score of Stage 3 or higher on the Functional Ambulation Scale.\n\nExclusion Criteria:\n\n* Having hearing or vision problems.\n* Participating in any exercise program.\n* Having accompanying other neurological, cardiovascular, or orthopedic disorders.\n* A history of an MS relapse or medication change within the last 6 months.\n* Being in a physical condition that prevents participation in exercises.\n* Comorbid conditions that negatively affect oxygen transport (e.g., severe anemia, peripheral artery disease, etc.)","65 Years",{"count":87,"type":22},73,"we aim to investigate the relationship between pelvic floor dysfunctions, core endurance, hip external rotation muscle strength, and tibialis posterior and tibialis anterior muscle activation in patients diagnosed with MS",[90,27],"Multiple Sclerosis",[92,93,94,95,96,97],"pelvic floor","multiple sclerosis","core endurance","tibialis anterior","tibialis posterior","electromyography","2026-02-18",{"date":100,"type":42},"2026-02-20",{"date":102,"type":42},"2025-01-01",{"date":104,"type":22},"2027-01-10",{"name":106,"class":48},"Berivan Beril Kılıç",{"id":108,"slug":109,"hasResults":11,"nctId":110,"briefTitle":111,"officialTitle":112,"acronym":113,"eligibilityCriteria":114,"healthyVolunteers":17,"sex":18,"minAge":19,"maxAge":115,"enrollmentInfo":116,"targetDuration":4,"studyType":118,"phases":119,"briefSummary":121,"conditions":122,"keywords":128,"overallStatus":38,"whyStopped":4,"lastUpdateSubmitDate":134,"lastUpdatePostDateStruct":135,"startDateStruct":137,"completionDateStruct":139,"leadSponsor":141,"locationsCount":49},"100625756","comparison-of-outpatient-rehabilitation-versus-self-training-for-the-treatment-and-prevention-of-postpartum-pelvic-floor-dysfunction-100625756","NCT07426770","Comparison of Outpatient Rehabilitation Versus Self-training for the Treatment and Prevention of Postpartum Pelvic Floor Dysfunction","Prevention of Female Pelvic Floor Dysfunction Rehabilitation Postpartum.","DDDPREV","Inclusion Criteria:\n\n* 18 years or older\n* This pregnancy was singleton\n* No contraindications for physical activity\n* No connective tissue disorders (for example Ehlers-Danlos syndrome)\n* No neurological disorders to influence pelvic floor symptoms (for example clinically significant spinal disc herniation)\n\nExclusion Criteria:\n\n* Younger than 18 years\n* Twins or triplet pregnancy\n* Contraindications for physical activity\n* Connective tissue disorders\n* Neurological disorders","50 Years",{"count":117,"type":22},80,"INTERVENTIONAL",[120],"NA","The main goal of this study to compare self-training postpartum and training with a specialist support (physiotherapist and physical medicine and rehabilitation doctor) effect on pelvic floor dysfunction prevention and treatment in postpartum period.\n\nHypothesis: The implementation of postpartum rehabilitation helps to alleviate existing symptoms of pelvic floor dysfunction and prevents pelvic floor dysfunction.\n\nStudy goals:\n\n* To objectively evaluate changes in pelvic organ position and pelvic floor muscle function in postpartum period, before and after specialised rehabilitation program\n* To objectively evaluate pelvic floor symptoms and their influence on woman life quality\n* To compare data (changes in pelvic floor muscle coordination and strength, pelvic organ position and changes in life quality according to validated questionnaires)\n\nStudy participants will:\n\n* Get an examination by obstetrician-gynaecologist, physical medicine and rehabilitation doctor and physiotherapist in 6 to 10 weeks postpartum period.\n* One group of participants will attend physiotherapy, biofeedback and electro stimulation procedures with a guidance of a specialist.\n* Other group of participants gets a recommendations and instructions of training and self-trains at home. To remind of training and help record training time \"squeezy\" app (an application designed for a mobile device) will be offered.\n* All groups of participants will be asked to fill life quality related questionnaires: (ICIQ-UI SF: International Consultation on Incontinence Questionnaire; P-QoL: Prolapse Quality-of-Life Questionnaire; PISQ-IR: Pelvic Organ Prolapse\u002F Urinary Incontinence Sexual Questionnaire IUGA revised; FSFI: female sexual function index; MOS-SF36 Medical Outcomes Study Short Form-36).",[27,123,124,125,126,127],"Postpartum Care","Postpartum Comfort","Female Urinary Incontinence and Pelvic Organ Prolapse","Rectus Diastasis","Sexual Dysfunction Female",[129,130,131,132,133],"Pelvic floor dysfunction postpartum","Postpartum urinary incontinence","Postpartum sexual dysfunction","Diastasis postpartum","Rehabilitation postpartum","2026-02-16",{"date":136,"type":42},"2026-02-23",{"date":138,"type":42},"2024-01-30",{"date":140,"type":22},"2029-09-30",{"name":142,"class":48},"Vilnius University",{"id":144,"slug":145,"hasResults":11,"nctId":146,"briefTitle":147,"officialTitle":148,"acronym":4,"eligibilityCriteria":149,"healthyVolunteers":11,"sex":18,"minAge":150,"maxAge":4,"enrollmentInfo":151,"targetDuration":4,"studyType":118,"phases":153,"briefSummary":154,"conditions":155,"keywords":157,"overallStatus":38,"whyStopped":4,"lastUpdateSubmitDate":161,"lastUpdatePostDateStruct":162,"startDateStruct":164,"completionDateStruct":166,"leadSponsor":168,"locationsCount":49},"100611626","ultrasound-and-electromyography-biofeedback-for-pelvic-floor-muscle-training-100611626","NCT07243028","Ultrasound and Electromyography Biofeedback for Pelvic Floor Muscle Training","Application of Simultaneous Pelvic Floor Ultrasonography and Electromyography Biofeedback on Pelvic Floor Muscle Training","Inclusion Criteria:\n\n1. Women aged 21 years or older diagnosed with pelvic floor muscle dysfunction and requiring pelvic floor muscle training (e.g., for symptomatic pelvic organ prolapse, stress urinary incontinence, or dysfunctional voiding).\n2. A Pelvic Floor Disability Index (PFDI-20) score greater than 1.\n3. Ability and willingness to provide written informed consent and authorization for the release of personal health information.\n4. Willingness and ability to complete all required questionnaires\n\nExclusion Criteria:\n\n1. Individuals planning a future pregnancy.\n2. Inability to read, understand, or sign the written consent form prior to participation.","21 Years",{"count":152,"type":22},70,[120],"This study aims to investigate the factors influencing adherence to pelvic floor muscle training (PFMT) devices among patients with pelvic floor dysfunction (PFD) through structured questionnaires, while simultaneously comparing the effectiveness of different feedback modalities, including non-invasive ultrasound imaging and invasive manometry with electromyography (EMG). By integrating subjective adherence data with objective performance outcomes, the project seeks to evaluate the potential of system-level integration for personalized therapeutic strategies, ultimately enhancing treatment efficacy, improving patient satisfaction, and promoting sustained engagement in PFMT.",[27,156],"Pelvic Floor Muscle Weakness",[35,158,159,160],"Pelvic floor muscle training","Health behavior","Biofeedback","2025-11-19",{"date":163,"type":42},"2025-11-21",{"date":165,"type":42},"2024-02-29",{"date":167,"type":22},"2028-12-31",{"name":169,"class":48},"National Cheng-Kung University Hospital",{"id":171,"slug":172,"hasResults":11,"nctId":173,"briefTitle":174,"officialTitle":175,"acronym":4,"eligibilityCriteria":176,"healthyVolunteers":17,"sex":18,"minAge":177,"maxAge":178,"enrollmentInfo":179,"targetDuration":4,"studyType":23,"phases":4,"briefSummary":181,"conditions":182,"keywords":4,"overallStatus":38,"whyStopped":4,"lastUpdateSubmitDate":184,"lastUpdatePostDateStruct":185,"startDateStruct":187,"completionDateStruct":189,"leadSponsor":191,"locationsCount":49},"100606820","prospective-clinical-trial-on-the-impact-of-uterine-firomatosis-on-pelvic-floor-100606820","NCT07180524","Prospective Clinical Trial on the Impact of Uterine Firomatosis on Pelvic Floor.","Prospective Clinical Trial on the Impact of Uterine Fibromatosis Surgery on Pelvic Floor.","Inclusion Criteria:\n\n* Symptomatic uterine fibromatosis with intramural and\u002For subserosal myomas identified by ultrasound and topographically mapped\n* Patients with scheduled hysterectomy or myomectomy\n\nExclusion Criteria:\n\n* suspicion of malignant lesion.\n* active tumors\n* previous history of chemotherapy or radiotherapy\n* pregnancy\n* age \\\u003C18 years or \\>55 years (postmenopause)\n* history of pelvic static disorders prior to surgery","35 Years","55 Years",{"count":180,"type":22},200,"Uterine fibromatosis is one of the most frequent gynecological conditions; in fact, uterine fibroids involve approximately 25-30% of women during the fertile period. Risk factors for the development of this pathology include age, family history and ethnicity. Multiparity, advanced age for pregnancy and smoking appear to be protective factors.\n\nMyomas are responsible for numerous symptoms reported by patients, such as menometrorrhagia, pelvic pain and urinary and\u002For deficatory symptoms. Although myomas are asymptomatic in almost 50% of cases, they represent the first cause of hysterectomy for benign pathologies (about 2\u002F3 of cases). Urinary symptoms associated with myomas are rarely studied in patients with symptomatic uterine fibromatosis; therefore the impact that this pathology has on the symptoms related to pelvic-perineal dysfunction and what their prevalence is is not well known at present. The prevalence of urinary symptoms in women with uterine myomas is highly variable based on literature data and the studies considered; in fact, the most frequently reported urinary symptoms are urinary urgency (31-59%), dysuria (4-36%) and stress urinary incontinence (20-80%). Furthermore, there is currently no unanimous agreement between the topography and size of myomas and related urinary and pelvic symptoms.\n\nThe type of treatment varies from single or multiple myomectomy to hysterectomy performed laparoscopically or laparotomy. The choice of surgical approach depends on the number, size and position of myomas. To date, few studies have evaluated the impact of the type of surgical treatment on pelvic floor symptoms. In fact, although hysterectomy is considered a risk factor for the onset of pelvic floor disorders, removal of the uterus can sometimes improve urinary symptoms. However, some authors report, equally, a significant improvement in urinary symptoms after myomectomy. Further studies are needed to clarify the impact of myoma treatment on urinary symptoms.",[27,183],"Fibromatosis","2025-09-16",{"date":186,"type":42},"2025-09-18",{"date":188,"type":42},"2024-06-30",{"date":190,"type":22},"2029-12-31",{"name":192,"class":48},"Fondazione IRCCS Policlinico San Matteo di Pavia",{"id":194,"slug":195,"hasResults":11,"nctId":196,"briefTitle":197,"officialTitle":197,"acronym":198,"eligibilityCriteria":199,"healthyVolunteers":11,"sex":18,"minAge":19,"maxAge":4,"enrollmentInfo":200,"targetDuration":4,"studyType":118,"phases":202,"briefSummary":203,"conditions":204,"keywords":207,"overallStatus":38,"whyStopped":4,"lastUpdateSubmitDate":215,"lastUpdatePostDateStruct":216,"startDateStruct":218,"completionDateStruct":220,"leadSponsor":222,"locationsCount":49},"100587135","effect-of-modified-mesh-on-surgical-success-in-transobturator-tape-surgery-100587135","NCT06924450","Effect of Modified Mesh on Surgical Success in Transobturator Tape Surgery","MOTOT","Inclusion Criteria:\n\n* Female patients aged 18 years or older\n* Clinical diagnosis of stress urinary incontinence (SUI), confirmed by:\n* Positive stress test (urine leakage on coughing with a comfortably full bladder)\n* Q-tip test showing urethral hypermobility (\\>30 degrees)\n* Inadequate response to conservative therapy (e.g., pelvic floor muscle training, behavioral therapy)\n* Eligible for transobturator tape (TOT) surgery\n* Body mass index (BMI) less than 35 kg\u002Fm²\n* Able to provide informed consent and follow postoperative instructions\n\nExclusion Criteria:\n\n* History of prior midurethral sling surgery\n* Mixed urinary incontinence or urge-dominant symptoms\n* Pelvic organ prolapse stage \\> II according to the POP-Q system\n* Neurological disorders affecting bladder function (e.g., multiple sclerosis, spinal cord injury)\n* Active urinary tract infection or recurrent UTI (defined as ≥3 infections within the past 12 months)\n* Pregnant or planning to become pregnant within the next 12 months\n* Severe comorbid conditions (e.g., uncontrolled diabetes mellitus, active malignancy, pelvic radiotherapy)\n* Use of medications that significantly affect bladder function (e.g., anticholinergics, diuretics)\n* Inability or unwillingness to attend follow-up visits or comply with postoperative care plan",{"count":201,"type":22},106,[120],"This study is a single-blind, randomized controlled trial evaluating whether changing the width of the surgical tape (mesh) used in transobturator tape (TOT) surgery improves treatment results in women with stress urinary incontinence (SUI). Two mesh widths are being compared: a 1.2 cm mesh (new method) and a 1.0 cm mesh (standard method). The main goal is to find out if the wider mesh leads to better urinary control and fewer complications. Participants will be followed for one year to measure cure rates, symptom improvement, and satisfaction.",[205,206,27],"Stress Urinary Incontinence","Female Urinary Incontinence",[62,208,209,210,211,212,213,214],"Stress Urinary Incontinence (SUI)","Female Pelvic Health","Transobturator Tape (TOT) Procedure","Pelvic Floor Surgery","Surgical Mesh","Randomized Controlled Trial","Urogynecology","2025-07-08",{"date":217,"type":42},"2025-07-11",{"date":219,"type":42},"2025-05-12",{"date":221,"type":22},"2025-11-12",{"name":223,"class":48},"Izzet Celegen",{"id":225,"slug":226,"hasResults":11,"nctId":227,"briefTitle":228,"officialTitle":228,"acronym":4,"eligibilityCriteria":229,"healthyVolunteers":17,"sex":18,"minAge":150,"maxAge":56,"enrollmentInfo":230,"targetDuration":4,"studyType":118,"phases":232,"briefSummary":233,"conditions":234,"keywords":245,"overallStatus":38,"whyStopped":4,"lastUpdateSubmitDate":254,"lastUpdatePostDateStruct":255,"startDateStruct":257,"completionDateStruct":259,"leadSponsor":261,"locationsCount":49},"100597993","transperineal-ultrasound-as-a-biofeedback-tool-for-pelvic-floor-muscle-therapy-in-postpartum-patients-100597993","NCT07065708","Transperineal Ultrasound as a Biofeedback Tool for Pelvic Floor Muscle Therapy in Postpartum Patients","Inclusion Criteria:\n\n* Female participants\n* Aged 21 - 45 years old.\n* Within 4 months of a singleton, vaginal delivery\n\nExclusion Criteria:\n\n* Currently pregnant\n* Over 4 months since vaginal birth.\n* Previous caesarean delivery.\n* Previous pelvic floor surgery (eg. pelvic floor repair, continence surgery, cervicetomy,cosmetic pelvic floor procedures)\n* Neurological disorder affecting muscle contraction (eg. Guillan-Barre syndrome, motorneuron disease, multiple sclerosis)",{"count":231,"type":22},94,[120],"Regular and effective pelvic floor muscle exercises after vaginal birth are crucial in reducing the risk of pelvic floor disorders in women. Pelvic floor muscle exercises are generally encouraged by healthcare providers to their patients after birth. However, it is often difficult to confirm whether a patient is performing pelvic floor muscle contractions correctly. A supervised pelvic floor physiotherapy session allows a professional to assess the pelvic floor and give their verbal feedback to patients. However even in this setting, patient's are reliant on the physiotherapist and have no way to assess their own performance. The 'biofeedback approach' allows for the clinician and patient to visually assess and modify their performance and can potentially allow for more effective therapy and better engagement. Transperineal ultrasonography is a widely available, safe and non-invasive biofeedback tool that can used at the bedside in order to assess pelvic floor muscle contractions. Our aim is to assess if using transperineal ultrasound can enhance the ability of postpartum patients to perform effective pelvic floor muscle therapy.",[235,236,237,238,239,240,241,27,242,243,244],"Pelvic Floor Muscle Training","Transperineal Ultrasound","Biofeedback Therapy","Postpartum","Pelvic Floor Disorder","Pelvic Floor Muscle Exercise","Pelvic Floor, Obstetric","Pelvic Floor Health After Childbirth","Physiotherapy","Physiotherapy Specialty",[246,247,248,249,250,251,252,253],"pelvic floor muscle training","biofeedback","transperineal ultrasound","pelvic floor exercises","physiotherapy","pelvic floor dysfunction","pelvic floor disorder","pelvic floor contraction","2025-07-03",{"date":256,"type":42},"2025-07-15",{"date":258,"type":42},"2025-05-20",{"date":260,"type":22},"2026-09",{"name":262,"class":48},"Singapore General Hospital",{"id":264,"slug":265,"hasResults":11,"nctId":266,"briefTitle":267,"officialTitle":268,"acronym":269,"eligibilityCriteria":270,"healthyVolunteers":11,"sex":271,"minAge":272,"maxAge":19,"enrollmentInfo":273,"targetDuration":4,"studyType":118,"phases":275,"briefSummary":276,"conditions":277,"keywords":280,"overallStatus":68,"whyStopped":4,"lastUpdateSubmitDate":285,"lastUpdatePostDateStruct":286,"startDateStruct":288,"completionDateStruct":290,"leadSponsor":292,"locationsCount":49},"100585989","home-pelvic-floor-improvement-trainer-trial-100585989","NCT06909539","HOme PElvic Floor Improvement Trainer Trial","Using a Perineometer Device With Gamification to Improve Symptom Outcomes in Pediatric Pelvic Floor Dysfunction","HoPE FIT","Inclusion Criteria:\n\n* Dysfunctional voiding symptoms without chronic pelvic pain.\n* Chronic pelvic pain with or without dysfunctional voiding symptoms.\n* Daytime enuresis, nocturnal enuresis, frequency, urgency, dysuria\n* 8 years - 18 years, no one under 8 and no one over 18.\n\nExclusion Criteria:\n\n\\- Has seen a physical therapist for traditional physical therapy of the pelvic floor due to urinary symptoms or chronic pelvic pain within the last 12 months.\n\nNote: This would include patients who begin physical therapy for their pelvic floor outside of the study while enrolled in the study.\n\n-All patients with the following conditions: severe developmental delay such as CP or wheelchair bound, cannot eat by mouth, mechanical ventilation dependence, etc.\n\n* Nonverbal or unable to effectively communicate needs and preferences.\n* Within the voiding dysfunction group, a diagnosis of a congenital GU anomaly (bladder exstrophy, cloacal anomaly, spina bifida, etc.)\n* No initial medication usage will be excluded; however, if the patient begins a new medication or treatment regimen during the study, the patient will be excluded.","ALL","8 Years",{"count":274,"type":22},150,[120],"This study will gauge the efficacy of a home biofeedback treatment device for pelvic floor dysfunction\u002Fvoiding dysfunction and pelvic pain. Investigators will test the utility of this device as a treatment alternative and\u002For temporary treatment for a patient's symptoms prior to or perhaps in lieu of their physical therapy appointment.",[278,27,279],"Pelvic Pain","Voiding Dysfunction",[281,251,282,283,284],"voiding dysfunction","pelvic pain","perineometer","gamification","2025-04-21",{"date":287,"type":42},"2025-04-24",{"date":289,"type":22},"2025-06-01",{"date":291,"type":22},"2027-01-01",{"name":293,"class":48},"University of Colorado, Denver",{"id":295,"slug":296,"hasResults":11,"nctId":297,"briefTitle":298,"officialTitle":299,"acronym":300,"eligibilityCriteria":301,"healthyVolunteers":17,"sex":271,"minAge":19,"maxAge":4,"enrollmentInfo":302,"targetDuration":4,"studyType":23,"phases":4,"briefSummary":303,"conditions":304,"keywords":307,"overallStatus":68,"whyStopped":4,"lastUpdateSubmitDate":316,"lastUpdatePostDateStruct":317,"startDateStruct":319,"completionDateStruct":321,"leadSponsor":323,"locationsCount":4},"100581309","impact-of-equestrian-sports-crossfit-and-gym-training-on-pelvic-floor-health-pelfisport--100581309","NCT06848634","Impact of Equestrian Sports, CrossFit, and Gym Training on Pelvic Floor Health (PELFISPORT )","Impact of Equestrian Sports, CrossFit, and Gym Training on Pelvic Floor Health in Athletes and Non-Athletes: A Cross-Sectional Study","PELFISPORT","Inclusion Criteria:\n\n* Adults 18 years or older.\n* Voluntary participation with signed informed consent.\n* Completion of the online survey.\n* For the sports groups (Equestrian, CrossFit, Gym, Other Sports):\n\n  * Minimum 2 years of experience in the sport.\n  * Minimum 2 training sessions per week.\n\nExclusion Criteria:\n\n* Individuals under 18 years old.\n* Participants who do not complete the survey.\n* Individuals with neurological conditions affecting mobility.\n* Individuals with mobility impairments unrelated to sports.\n* Sports participants with less than 2 years of experience or training less than twice per week.",{"count":180,"type":22},"This observational cross-sectional study investigates the impact of equestrian sports, CrossFit, and gym training on pelvic floor health in both athletes and non-athletes. The study aims to determine whether specific sports are associated with a higher risk of pelvic floor dysfunction, including urinary incontinence, pelvic organ prolapse, and chronic pelvic pain.\n\nParticipants will complete an online survey that collects demographic information, sports participation details, and pelvic floor health symptoms. The survey includes standardized questionnaires to assess pelvic floor function. Data will be analyzed to compare the prevalence of pelvic floor issues among different sports and between athletes and non-athletes.\n\nThe study seeks to provide insights into how sports participation influences pelvic health and to raise awareness of pelvic floor dysfunction in both male and female athletes.",[27,62,305,306],"Pelvic Organ Prolapse (POP)","Chronic Pelvic Pain",[308,309,310,311,312,313,314,315],"Urinary incontinence","Pelvic organ prolapse","Chronic pelvic pain","Equestrian sports","CrossFit","Gym training","Women's health","Physical activity","2025-02-26",{"date":318,"type":42},"2025-02-27",{"date":320,"type":22},"2025-02-28",{"date":322,"type":22},"2025-04-05",{"name":324,"class":48},"University of Oviedo",{"id":326,"slug":327,"hasResults":11,"nctId":328,"briefTitle":329,"officialTitle":329,"acronym":4,"eligibilityCriteria":330,"healthyVolunteers":11,"sex":18,"minAge":19,"maxAge":4,"enrollmentInfo":331,"targetDuration":4,"studyType":118,"phases":333,"briefSummary":334,"conditions":335,"keywords":4,"overallStatus":38,"whyStopped":4,"lastUpdateSubmitDate":337,"lastUpdatePostDateStruct":338,"startDateStruct":340,"completionDateStruct":342,"leadSponsor":344,"locationsCount":49},"100568155","vibrator-use-to-improve-sexual-and-pelvic-floor-function-among-urogynecology-patients-100568155","NCT06677541","Vibrator Use to Improve Sexual and Pelvic Floor Function Among Urogynecology Patients","Inclusion Criteria:\n\n* • Women aged 18 and over presenting to the urogynecology clinic.\n\n  * Women diagnosed with one of the following urogynecologic conditions\n\n    o Pelvic organ prolapse, urgency incontinence, overactive bladder, stress urinary incontinence, fecal incontinence, recovering from a urogynecologic surgery over 6 weeks following surgery and clear for intercourse. Patients post op who continue to have pelvic floor dysfunction can be candidates for the study if they continue to have one of the pelvic floor dysfunctions listed.\n  * Patient will be screened with the FSFI and will be eligible if they score less than 26.55\n  * Patient's must be willing to use a vibrator.\n  * Able to provide informed consent.\n  * Not currently using a vibrator or has not used a vibrator in the past 3 months.\n  * Able to read and write in English\n\nExclusion Criteria:\n\n* • Patients with cognitive impairment.\n\n  * Patients with refusal or discomfort with vibrator use.\n  * Currently using a vibrator or has used a vibrator in the past 3 months.\n  * Patients unable to provide informed consent.\n  * Patients not clear for intercourse following their surgery\n  * Patients with surgery within 2 months of recruitment.",{"count":332,"type":22},84,[120],"Limited data exist describing the use and role of vibrators in a urogynecology population and no randomized controlled trials investigating the use of vibrators as a therapeutic tool to enhance sexual and pelvic floor function in urogynecology patients has been conducted. This study aims to evaluate the efficacy of vibrator use in improving sexual and pelvic floor function in urogynecology patients who report sexual dysfunction.",[27,127,336],"Vibrator","2025-01-14",{"date":339,"type":42},"2025-01-15",{"date":341,"type":42},"2024-11-01",{"date":343,"type":22},"2026-01-31",{"name":345,"class":48},"Albany Medical College"]